Kanker Payudara - Page 303 of 303 -

Navigating the Hardest Conversation: A Guide for Families Facing Terminal Illness navigating-the-hardest-conversation-a-guide-for-families-facing-terminal-illness

navigating-the-hardest-conversation-a-guide-for-families-facing-terminal-illness

Navigating the Hardest Conversation: A Guide for Families Facing Terminal Illness

Dwi Wanna July 24, 2025

Written by Kelsey Mora, Certified Child Life Specialist (CCLS), Licensed Clinical Professional Counselor (LCPC), and Chief Clinical...

Breakthrough in Pathology: New Molecular Markers Identified to Distinguish Between Rare Langerhans Cell Neoplasms breakthrough-in-pathology-new-molecular-markers-identified-to-distinguish-between-rare-langerhans-cell-neoplasms

breakthrough-in-pathology-new-molecular-markers-identified-to-distinguish-between-rare-langerhans-cell-neoplasms

Breakthrough in Pathology: New Molecular Markers Identified to Distinguish Between Rare Langerhans Cell Neoplasms

Layla Zulfa July 23, 2025

Main Facts: Solving a Diagnostic Dilemma Langerhans cell sarcoma (LCS) is an exceptionally rare, highly aggressive malignant...

The Vanguard of Hope: How Breast Cancer Canada is Redefining the Patient Experience through Innovation and Research the-vanguard-of-hope-how-breast-cancer-canada-is-redefining-the-patient-experience-through-innovation-and-research

the-vanguard-of-hope-how-breast-cancer-canada-is-redefining-the-patient-experience-through-innovation-and-research

The Vanguard of Hope: How Breast Cancer Canada is Redefining the Patient Experience through Innovation and Research

Nila Kartika Wati July 12, 2025

Introduction: A New Era in Oncology In the landscape of modern medicine, the fight against breast cancer...